 |
|
Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
Ho Soo Chun, A Reum Choe, Minjong Lee, Yuri Cho, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
Clin Mol Hepatol. 2021;27(4):535-552. Published online 2021 Jun 16 DOI: https://doi.org/10.3350/cmh.2021.0109
|
|
Citations to this article as recorded by
 Experience With Dabigatran on Rate of Portal Vein Thrombosis Recanalization, Disease Progression and Survival
Madhumita Premkumar, Harish Bhujade, Prerna Sharma, Jasvinder Nain, Jasmina Ahluwalia, Anchal Sandhu, Yogendra Kumar, Sahaj Rathi, Sunil Taneja, Ajay Kumar Duseja, Anand V. Kulkarni, Charanpreet Singh, Shano Naseem, Tanka Karki, Pankaj Gupta, Sreedhara B.
Alimentary Pharmacology & Therapeutics.2025; 61(6): 971. CrossRef Comprehensive approach to liver cirrhosis treatment: Integrating ayurveda, homeopathy, and allopathy
Debabrata Dash, Palak Kesharwani, Raj Kumar Koiri
Pharmacological Research - Natural Products.2025; 6: 100184. CrossRef The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis
Seema Sharma, Nishant Tiwari, Sampat Singh Tanwar
Naunyn-Schmiedeberg's Archives of Pharmacology.2025;[Epub] CrossRef Analysis of Related Influencing Factors of Portal Vein Thrombosis After Hepatectomy
ShiGuai Qi, Jie Tao, Xinhua Wu, Xu Feng, Guoying Feng, Zhengrong Shi
Journal of Laparoendoscopic & Advanced Surgical Techniques.2024; 34(3): 246. CrossRef Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin in Cirrhotic Patients: A Systematic Review and Meta-Analysis
Chunwei Cheng, Juan Hua, Liang Xiong
Clinical and Applied Thrombosis/Hemostasis.2024;[Epub] CrossRef Direct Oral Anticoagulants Versus Traditional Anticoagulation in Cirrhotic Patients with Portal Vein Thrombosis: Updated Systematic Review
Xiulin Xiao, Wengen Zhu, Qixin Dai
Clinical and Applied Thrombosis/Hemostasis.2024;[Epub] CrossRef Portal Vein Variations, Clinical Correlation, and Embryological Explanation: A Review Article
Gareema Tyagi, Roshan K Jha
Cureus.2023;[Epub] CrossRef THE SURGEON'S PERSPECTIVE ON PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS
S.M. Vasyliuk, V.I. Hudyvok, І.R. Labiak, N.M. Pavliuk, V.M. Atamaniuk
Art of Medicine.2023; : 152. CrossRef Heparins for prevention and treatment of venous thromboembolism in cirrhosis: Research advances
Zhe Li, Wen-Tao Xu, Xiang-Bo Xu, Xing-Shun Qi
World Chinese Journal of Digestology.2022; 30(9): 381. CrossRef Letter to the editor: Treating portal vein thrombosis in cirrhosis: is anticoagulation therapy overestimated?
Xiaobing Wang, Liping Chen
Hepatology International.2022; 16(5): 1248. CrossRef Direct oral anticoagulants (DOACs): From the laboratory point of view
Sandra Margetić, Sandra Šupraha Goreta, Ivana Ćelap, Marija Razum
Acta Pharmaceutica.2022; 72(4): 459. CrossRef
|